Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-07
1997-08-05
Wilson, James O.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 48, 514 51, 514256, 514261, 514269, 514861, 514863, 514887, 536 2626, 536 267, 536 268, 544242, 544264, A61K 31505, A61K 3152, A61K 3170
Patent
active
056542860
ABSTRACT:
Typical treatment of psoriasis and other diseases of skin cell hyperproliferation using pharmaceutical compositions containing mono-, di, and tri-phosphate esters of antiproliferative nucleoside analogs and related analogs, DNA chain-terminating dideoxynucleosides and other nucleoside analogs. The useful phosphate esters include phosphoramidates and phosphothiorates, as well as polyphosphates having C and S bridging atoms.
REFERENCES:
patent: 2795580 (1957-06-01), Khorana et al.
patent: 2970139 (1961-01-01), Duschinsky et al.
patent: 3238191 (1966-03-01), Myers
patent: 4088756 (1978-05-01), Voorhees
patent: 4146715 (1979-03-01), Schaeffer
patent: 4199574 (1980-04-01), Schaeffer
patent: 4207315 (1980-06-01), Voorhees et al.
patent: 4211770 (1980-07-01), Voorhees
patent: 4294831 (1981-10-01), Schaeffer
patent: 4297347 (1981-10-01), Katsunoma
patent: 4323573 (1982-04-01), Schaeffer
patent: 4360522 (1982-11-01), Schaeffer
patent: 4634719 (1987-01-01), Takaishi et al.
patent: 4758572 (1988-07-01), Spector et al.
patent: 4804651 (1989-02-01), Duvic et al.
patent: 4897394 (1990-01-01), Zimmerman et al.
patent: 5021437 (1991-06-01), Blumenkopf
patent: 5068320 (1991-11-01), Koszalka et al.
patent: 5089500 (1992-02-01), Daluge
patent: 5093114 (1992-03-01), Rideout et al.
patent: 5128458 (1992-07-01), Montgomery et al.
patent: 5223262 (1993-06-01), Hostetler et al.
patent: 5478928 (1995-12-01), Montgomery et al.
Carson, D., et al. (1992) Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine. Proc. Natl. Acad. Sci. 89:2970-2974.
Eibschutz, B., et al. (1995) Oral 2-chlorodeoxyadenosine in psoriatic arthritis. Arthritis & Rheumatism 38(11):1604-1609.
Lesiewicz, J., et al. (1985) Animal screens for retinoids. Models in Dermatology 2:112-116.
Agranoff, B. et al. (1963) Cytidine Diphosphatase - dl - Dipalmitin. Biochem. Prep. 10:47-51.
Ellis, M. et al. (1989) Orofacial infection of athymic mice with defined mixtures of acyclovir-susceptible and acyclovir-resistant herpes simplex virus type 1. Antimicrobial Agents and Chemotherapy 33(3):304-310.
Furman, P. et al. (1979) Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate. J. Virol. 32:72-77.
Fyfe, J. et al. (1978) Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9(2-hydroxyethoxymethyl)guanine. J. Biol. Chem. 253:8721-8727.
Gomez-almaguer, D. et al. (1988) Acyclovir in the treatment of aplastic anemia. Amer. J. of Hematology 29:172-173.
King (1988) History, pharmacokinetics, and pharmacology of acyclover. J. Am. Acad. Dermatol. 18:176-179 (Abstract only).
Krenitsky, T. et al. (1990) Nucleotide analogue inhibitors of purine nucleoside phosphorylase. The Journal of Biological Chemistry 265(6):3066-3069.
Lobe, D. et al. (1991) Synergistic topical therapy by acyclovir and A11OU for herpes simplex virus induced zosteriform rash in mice. Antiviral Research 15:87-100.
Masch et al. (1965) Nivea, the Prototype of Lanolin Absorption Creams. A history of Nivea Cream. American Perfumer and Cosmetics 80:35-38.
Merta et al. (1990) Inhibition of herpes simplex virus DNA polymerase by diphosphates of acyclic phosphonylmethoxyalkyl nucleotide analogues. Antiviral Research 13:209-218.
O'Brien, W. et al. (1990) Nucleoside metabolism simplex virus-infected cells following treatement with interferon and acyclovir, a possible mechanism of synergistic antiviral activity. Antimicrob. Agents and Chemother. 34(6):1178-1182.
Ott, D.G. et al. (1967) Chemical synthesis of nucleoside triphosphates. Anal. Biochem. 21:469-472.
Remington's Pharmaceutical Sciences, 15th Edition., 175. Mack Publishing Company., Easton, Pennsylvania 18042. (Chapter 87: Blaug. Seymour).
Rune, S.J. et al. (1990) Acyclovir in the prevention of duodenal ulcer recurrence. Gut 31:151-152.
Spruance, S. et al. (1982) Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J. Infect. Dis. 146:85-90.
Spruance, S. et al. (1984) Early patient-initated treatment of herpes labialis with topical 10% acyclovir. Antimicrob. Agents Chemother. 25:553-555.
Straus, S. (1989) Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes. Sexually Transmitted Diseases 16(2):107-113.
Toorchen, D. et al. (1983) Mechanisms of chemical mutagenesis and carcinogenesis: effects on DNA replication of methylation at the 06-guanine position of dGTP. Carcinogenesis 4:1591-1597.
Welch, C.J. et al. (1985) The chemical synthesis and antiviral properties of an acyclovir-phospholipid conjugate. Acta Chemica Scandinavica B39:47-54.
Whitley, R. et al. (1990) Immunobiology and Prophylaxis of Human Herpevirus Infections, C. Lopez (ed). Plenum Press, New York pp. 243-253.
Yoshikawa, M. et al. (1969) Phosphorylation. III. Selective phosphorylation of unprotected nucleosides. Bull. Chem. Soc. Japan 42:3505-3508.
Yoshikawa, et al. (1967) A novel method for phosphorylation of nucleosides to 5'-nucleotides. Tetrahedron Lett., 50:5065-5068.
Bauer, E., et al. (1989) Psoriasis and other proliferative disorder of epithelium. In Textbook of Internal Medicine, W.N. Kelly (ed.) pp. 1042-1045.
Chan, E, et al. (1982) Total synthesis of (8R)-3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo l[4,5-d][1,3]diazepin-8-ol . . . J. Org. Chem. 47:3457-3464.
Fox, J., et al. (1958) Thiation of Nucleosides. I. synthesis of 1-Amino-6-mercapto-9-.beta.-D-ribofuranosylpurine ("thioguanosine") and related purine nucleosides. J. Am. Chem. Soc. 28:1669-1675.
Grove, G. (1979) Epidermal cell kinetics in psoriasis. J. Dermatol. 18:111-122.
Gutowski, G., et al. (1973) Pyrazomycin B: isolation and characterization of an .alpha.-C-nucleoside antibiotic related to pyrazomycin. Biochemical and Biophysical Research Communications 51(2):312-317.
Henderson, J. and Paterson, A., Nucleoside Metabolism (Academic Press, 1973) New York pp. 266-271.
Hoard, D., et al. (1965) Conversion of mono- and oligodeoxyribonucleotides to 5'-triphosphates. J. Am. Chem. Soc. 87(8):1785-1788.
Hunt, B., et al. (1967) Methods, apparatus: new product reasearch, process development and design. Chemistry and Industry pp. 1868-1869.
Hutchinson, D. (1991) The synthesis, reactions, and properties of nucleoside mono-, di-, tri-, and tetraphosphates and nucleotides with changes in the phosphoryl residue. In Chemistry of Nucleotides and Nucleosides, (L. Townsend, ed.), pp. 81-1460.
Lowe, N. (1988) Psoriasis: in vivo models for topical drug evaluation. Drug Development Research 13:147-155.
McDonald, C. (1981) The uses of systemic chemotherapeutic agents in psoriasis. Pharmac. Ther. 14:1-24.
Moffatt, J., et al. (1961) Nucleoside polyphosphates. XII. The total synthesis of Coenzyme A.sup.2. J. Am. Chem. soc. 83:663-675.
Myers, T., et al. (1963) Phosphonic acid analogs of nucleoside phosphates. I. the synthesis of 5'-adenylyl methylenediphosphonate, a phosphonic acid analog of ATP. J. of Am. Chem. Soc. 85:3295-3295.
Robins, R., et al. (1963) Aromaticity in heterocyclic systems. I. the synthesis ans structure of certain 4'6-dihydroxyimidazo[4,5-c]pyridines. J. Org. Chem. 28:3041-3046.
Robins, R., et al. Purines and purine nucleoside analogues as antitumor agents. in The Chemistry of Antitumor Agents. D.E.V. Wilman, ed. (1990) Blackie London. pp. 300-321.
Seela, F., et al. (1992) 7-deazapurine containing DNA: efficiency of C.sup.7 G.sub.d TP, and C.sup.7 A.sub.d TP and C.sup.7 I.sub.d TP incorporation during PCR-amplification and protection from endodeoxyribonuclease hydrolysis. Nucleic Acids Research 20(1):55-61.
Sundberg, J., et al. (1989) The flaky skin (fsn) mutation, chromosome! J. Invest. Dermatol. 92:414.
van Boom, J., et al. (1975) 2,2,2-tribromoethyl phosphoromorpholinochloridate: a convenient reagent for the synthesis of ribonucleoside mono-, di- and tri-phosphates.
Yount, R. G. ATP analogs. in Advances in Enzymology, (F.F. Nord ed. 1975) J. Wiley, New York, 43:1-56.
LandOfFree
Nucleotides for topical treatment of psoriasis, and methods for does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleotides for topical treatment of psoriasis, and methods for , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleotides for topical treatment of psoriasis, and methods for will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1074880